Catalent Publishes Fourth Annual Corporate Responsibility Report Highlighting Achievements While Providing New Record Number of Patient Treatments
March 01, 2023
March 01, 2023
SOMERSET, New Jersey, March 1 (TNSrpt) -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on Feb. 28, 2023:
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today published its fourth Corporate Responsibility Report. for its fiscal year 2022, which ended June 30, 2022. The report highlights Catalent's progress against its previously published targets and commitment . . .
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today published its fourth Corporate Responsibility Report. for its fiscal year 2022, which ended June 30, 2022. The report highlights Catalent's progress against its previously published targets and commitment . . .